Zenagamtide: Clinical Trials

5 recruiting, 2 not yet recruiting. 5 Phase 3, 2 Phase 1.

By phase and status

Phase	Trials	Status
Phase 3	5	Recruiting 3, Not yet recruiting 2
Phase 1	2	Recruiting 2

Follow Zenagamtide: new trials by email Literature Review of Zenagamtide trials Research Report on Zenagamtide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
AMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose Weight Zenagamtide, Placebo ( matched to Zenagamtide) - Obesity, Overweight	Phase 3	Not yet recruiting	Novo Nordisk A/S	400	2027-01-07	2026-08-24
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity Zenagamtide, Placebo - Cardiovascular Risk, Obesity	Phase 3	Not yet recruiting	Novo Nordisk A/S	8500	2026-10-26	2026-10-06
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication Tirzepatide, Zenagamtide - Overweight, Obesity	Phase 1	Recruiting	Novo Nordisk A/S	60	2026-10-08	2026-10-16
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide Medication Semaglutide, Zenagamtide - Overweight, Obesity	Phase 1	Recruiting	Novo Nordisk A/S	60	2026-10-05	2026-10-16
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide Zenagamtide, Semaglutide, Placebo (matched to semaglutide) - Overweight, Obesity	Phase 3	Recruiting	Novo Nordisk A/S	650	2026-09-22	2026-09-28
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight zenagamtide, Placebo - Overweight, Obesity	Phase 3	Recruiting	Novo Nordisk A/S	950	2026-08-31	2026-09-28
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications Zenagamtide, Insulin glargine U-100 - Type 2 Diabetes, Cardiovascular Risk	Phase 3	Recruiting	Novo Nordisk A/S	1778	2026-08-24	2026-09-01

Conditions studied

Obesity (6)  ·  Overweight (5)  ·  Diabetes Mellitus, Type 2 (3)

Sponsors

Novo Nordisk A/S (7)

Countries

United States (6)  ·  India (3)  ·  Argentina (2)  ·  Brazil (2)  ·  Bulgaria (2)  ·  Canada (2)  ·  China (2)  ·  Czechia (2)  ·  Germany (2)  ·  Greece (2)  ·  Italy (2)  ·  Japan (2)  ·  Malaysia (2)  ·  Mexico (2)  ·  Poland (2)